Your browser doesn't support javascript.
loading
Elective neck dissection for T3/T4 cN0 sinonasal squamous cell carcinoma.
Crawford, Kayva L; Jafari, Aria; Qualliotine, Jesse R; Stuart, Emelia; DeConde, Adam S; Califano, Joseph A; Orosco, Ryan K.
Afiliación
  • Crawford KL; Division of Otolaryngology-Head & Neck Surgery, Department of Surgery, University of California San Diego, San Diego, California, USA.
  • Jafari A; Department of Otolaryngology-Head & Neck Surgery, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.
  • Qualliotine JR; Department of Otolaryngology-Head & Neck Surgery, Harvard Medical School, Boston, Massachusetts, USA.
  • Stuart E; Division of Otolaryngology-Head & Neck Surgery, Department of Surgery, University of California San Diego, San Diego, California, USA.
  • DeConde AS; School of Medicine, University of California San Diego, San Diego, California, USA.
  • Califano JA; Division of Otolaryngology-Head & Neck Surgery, Department of Surgery, University of California San Diego, San Diego, California, USA.
  • Orosco RK; Division of Otolaryngology-Head & Neck Surgery, Department of Surgery, University of California San Diego, San Diego, California, USA.
Head Neck ; 42(12): 3655-3662, 2020 12.
Article en En | MEDLINE | ID: mdl-32830895
ABSTRACT

BACKGROUND:

In locally advanced sinonasal squamous cell carcinoma (SNSCC), management of the clinically node-negative (cN0) neck is variable and elective neck dissection (END) remains controversial.

METHODS:

Patients with surgically treated T3/T4 cN0 M0 SNSCC were identified using the NCDB. Overall survival (OS) was assessed by Cox proportional hazard analysis in propensity score-matched cohorts. Factors associated with END were evaluated with logistic regression.

RESULTS:

Two hundred twenty patients underwent END (19.6%). END did not correlated with OS in propensity score-matched cohorts (HR 0.971, 95% CI 0.677-1.392), a maxillary sinus tumor subgroup (HR 1.089, 95% CI 0.742-1.599), or by radiation status [radiation (HR 0.802, 95% CI 0.584-1.102); no radiation (HR 0.852, 95% CI 0.502-1.445)]. The occult metastasis rate in the END cohort was 12.7%.

CONCLUSION:

END did not significantly improve OS in this study. Further information on disease-free survival is necessary to determine its role in advanced-stage SNSCC.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Disección del Cuello / Carcinoma de Células Escamosas Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Head Neck Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Disección del Cuello / Carcinoma de Células Escamosas Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Head Neck Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos